Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Thai CL Policy Estimated Worth $253 Million Over Five Years

This article was originally published in PharmAsia News

Executive Summary

Thailand's policy decision regarding compulsory licensing for key foreign drugs could be worth $253.2 million to the nation over the next five years, the government has estimated. A committee considering whether to keep or drop the compulsory licensing policy is expected to submit the estimate to the Public Health Ministry. The figure is based in part on estimates of the number of new cancer cases expected to be reported this year through 2012. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC068124

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel